3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
2
Conditions
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Neoplasms
1
Hodgkin Disease
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
tanespimycin
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
glucarpidase
2
ensartinib
2
Vemurafenib
2
Triptorelin Pamoate
2
Psychiatric Rehabilitation
2
Leucovorin
2
LY3023414
2
Electroacupuncture
2
Drug Therapy
2
Carboplatin
2
trimetrexate glucuronate
1
surufatinib
1
ixabepilone
1
gamma-Glutamyl Hydrolase
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Triptorelin Pamoate
×
Lymphoid
×
Clear all
NCT05328258
2023-10-27
ProFertil
Karolinska University Hospital
Phase 3
Recruiting
500 enrolled
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled